Reply by Authors.

Lo, Glen; Burton, Kirsteen R; Haider, Masoom A; Fleshner, Neil; Finelli, Antonio; Ghai, Sangeet

Reply by Authors.

Lo, Glen; Burton, Kirsteen R; Haider, Masoom A; Fleshner, Neil; Finelli, Antonio; Ghai, Sangeet.

Afiliación

Lo G; Diagnostic Imaging, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
Burton KR; Joint Dept of Medical Imaging, University Health Network, Mt Sinai Hospital, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
Haider MA; Joint Dept of Medical Imaging, University Health Network, Mt Sinai Hospital, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
Fleshner N; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Finelli A; Joint Dept of Medical Imaging, University Health Network, Mt Sinai Hospital, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
Ghai S; Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, Ontario, Canada.

J Urol ; 202(6): 1165, 2019 12.

Article en En | MEDLINE | ID: mdl-31469610

Asunto(s)

Antígeno Prostático Específico; Próstata; Biopsia; Humanos; Imagen por Resonancia Magnética; Masculino; Estudios Retrospectivos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Próstata / Antígeno Prostático Específico Tipo de estudio: Observational_studies Límite: Humans / Male Idioma: En Revista: J Urol Año: 2019 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google